Capital7 invests in Allied BioScience
Allied BioScience, a maker of residual antiviral surface coating, has secured an undisclosed amount of Series C funding.
Allied BioScience, a maker of residual antiviral surface coating, has secured an undisclosed amount of Series C funding.
Copyright PEI Media
Not for publication, email or dissemination